American Heart Journal
Volume 160, Issue 2 , Pages 355-361 , August 2010

Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents

  • Stefanie Schulz, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • Corresponding Author InformationReprint requests: Stefanie Schulz, MD, Deutsches Herzzentrum, Lazarettstr. 36, 80636 Munich, Germany.
    • ,
  • Dirk Sibbing, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Sigmund Braun, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Tanja Morath, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Julinda Mehilli, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Steffen Massberg, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Robert A. Byrne, MB BCh

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • ,
  • Albert Schömig, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany
    • First Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany
    • ,
  • Adnan Kastrati, MD

      Affiliations

    • Deutsches Herzzentrum, Technische Universität, Munich, Germany

Received 12 March 2010 ,Accepted 6 May 2010.

References 

  1. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030–1039
  2. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334:1084–1089
  3. Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53:849–856
  4. Willerson JT, Yao SK, McNatt J, et al. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA. 1991;88:10624–10628
  5. Unterberg C, Sandrock D, Nebendahl K, et al. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol. 1995;26:1747–1754
  6. Evans DJ, Jackman LE, Chamberlain J, et al. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis. Circulation. 2009;119:116–122
  7. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  8. The TIMI Study Group. Definitions used in TIMI trials. Available at http://www.timi.orgLast accessed August 10th, 2009
  9. Ip JH, Fuster V, Israel D, et al. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17:77B–88B
  10. Le Breton H, Plow EF, Topol EJ. Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol. 1996;28:1643–1651
  11. Ali S, Davis MG, Becker MW, et al. Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor. J Biol Chem. 1993;268:17397–17403
  12. Ferns GA, Raines EW, Sprugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129–1132
  13. Crowley ST, Dempsey EC, Horwitz KB, et al. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation. 1994;90:1908–1918
  14. Weiss RH, Nuccitelli R. Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J Biol Chem. 1992;267:5608–5613
  15. Hermann A, Rauch BH, Braun M, et al. Platelet CD40 ligand (CD40L)—subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets. 2001;12:74–82
  16. Evangelista V, Manarini S, Dell'Elba G, et al. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost. 2005;94:568–577
  17. Hermann A, Weber AA, Schror K. Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells. Thromb Res. 2002;105:173–175
  18. Herbert JM, Tissinier A, Defreyn G, et al. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb. 1993;13:1171–1179
  19. Taylor RR, Gibbons FA, Cope GD, et al. Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol. 1991;68:874–878
  20. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988;318:1714–1719
  21. Kastrati A, Schuhlen H, Hausleiter J, et al. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation. 1997;96:462–467
  22. Urban P, Buller N, Fox K, et al. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J. 1988;60:485–488
  23. Ellis SG, Roubin GS, Wilentz J, et al. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777–782
  24. Serruys PW, Herrman JP, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. N Engl J Med. 1995;333:757–763
  25. Serruys PW, Rutsch W, Heyndrickx GR, et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT). Circulation. 1991;84:1568–1580
  26. Savage MP, Goldberg S, Bove AA, et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation. 1995;92:3194–3200
  27. Muller I, Seyfarth M, Rudiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart. 2001;85:92–93
  28. von Beckerath N, Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation. 2005;112:2946–2950
  29. Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation. 1999;100:2477–2484
  30. Mehilli J, Kastrati A, Schuhlen H, et al. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation. 2004;110:3627–3635
  31. Choi ET, Engel L, Callow AD, et al. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994;19:125–134
  32. Lundgren CH, Sawa H, Fujii S. Inhibition of neointimal hyperplasia after balloon injury by local delivery of cyclic arginine-glycine-aspartic acid peptide targeting vitronectin receptor. [abstract] J Am Coll Cardiol. 1995;83A:25
  33. Friedman RJ, Stemerman MB, Wenz B, et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest. 1977;60:1191–1201

PII: S0002-8703(10)00354-6

doi: 10.1016/j.ahj.2010.05.003

American Heart Journal
Volume 160, Issue 2 , Pages 355-361 , August 2010

Article Tools

* Image Usage & Resolution